Trial intelligence / Profile preview

Anakinra in corticosteroid-resistant SSNHL

NCT02414152Phase 2Terminated

Start
Oct 2013
Primary completion
Jul 2015
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in sudden sensorineural hearing loss (SSHL). Started Oct 2013; status: terminated.

02

Drugs

anakinra
03

Conditions

sudden sensorineural hearing loss (SSHL)

Beyond the preview

Go deeper on NCT02414152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02414152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call